Investment analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for shares of Quest ...

Redburn Atlantic began coverage on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a report issued on Wednesday morning, MarketBeat reports. The firm issued a buy rating and a $195.00 price ...

At a meeting with analysts and investors at its 2025 Investor Day, members of the leadership team of Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services ...

NEW YORK, April 11, 2025 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up ...

Commentary on tariffs and the consumer will be in the spotlight March core CPI forecast to drop to annual rate of 3% Bill ...

Shares of Quest Diagnostics Inc. DGX slid 2.74% to $159.80 Tuesday, on what proved to be an all-around dismal trading session ...

Quest Diagnostics Inc. closed 8.28% below its 52-week high of $178.87, which the company reached on March 10th.

Mizuho raised the firm’s price target on Quest Diagnostics (DGX) to $189 from $178 and keeps an Outperform rating on the shares. The firm ...

Valued at a market cap of $18.2 billion, Quest Diagnostics Incorporated (DGX) provides diagnostic testing and services in the ...

Stay ahead in financial markets with Seeking Alpha's Wall Street Week Ahead as big banks are set to report earnings this week.

TORONTO - Canadian and U.S. stock markets are sinking for a third straight day as U.S. President Trump’s tariffs stir global recession fears. The S&P/TSX composite index was trading down 825.74 ...

"Before markets opened, Hassett was asked if Trump would consider doing a 90-day pause, and he punted on the question," according to The Hill. Billionaire hedge fund investor Bill Ackman ...